The benefits of early treatment in rheumatoid arthritis: Confounding by indication, and the issue of timing
Open Access
- 10 January 2003
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (1) , 1-5
- https://doi.org/10.1002/art.10732
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception studyArthritis & Rheumatism, 2003
- Follow up studies in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2002
- COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief interventionArthritis & Rheumatism, 2002
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and MethotrexateArchives of internal medicine (1960), 1999
- Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trialThe Lancet, 1999
- The Effectiveness of Early Treatment with “Second-Line” Antirheumatic DrugsAnnals of Internal Medicine, 1996
- Informative Drop-Out in Longitudinal Data AnalysisJournal of the Royal Statistical Society Series C: Applied Statistics, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988